2,761
Participants
Start Date
May 26, 2021
Primary Completion Date
September 23, 2024
Study Completion Date
September 23, 2024
Cardiovascular disease risk assessment
Intervention in which the addition of guideline-recommended absolute cardiovascular disease risk assessment is embedded into point-of-care blood collection services for cholesterol measurement and results (including risk score) are reported to referring doctors.
Usual care assessment
Usual care in which blood cholesterol results are reported to referring doctors
Menzies Institute for Medical Research, Hobart
Lead Sponsor
Collaborators (2)
National Health and Medical Research Council, Australia
OTHER
Diagnostic Services Pty Ltd
UNKNOWN
Department of Health, Tasmania
OTHER_GOV
Primary Health Tasmania
UNKNOWN
National Heart Foundation, Australia
OTHER
Healthcare Software Pty Ltd
UNKNOWN
Uscom Limited
UNKNOWN
Menzies Institute for Medical Research
OTHER